A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03895372. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 2, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PF-06826647 IN PARTICIPANTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This multicenter study is being conducted to provide additional PF-06826647 safety and tolerability data, and to further explore the clinical efficacy of PF-06826647 in the treatment of moderate to severe plaque psoriasis. Additionally, the study is intended to enable selection of oral dose and dosing regimen for the future clinical development of PF-06826647.
Study identification
- NCT ID
- NCT03895372
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 179 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 27, 2019 (Actual)
- Primary completion
- May 21, 2020 (Actual)
- Completion
- Nov 26, 2020 (Actual)
- Last update posted
- Aug 27, 2021
2019 – 2020
United States locations
- U.S. sites
- 24
- U.S. states
- 9
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alliance Dermatology and Mohs Center | Phoenix | Arizona | 85032 | — |
| Center for Dermatology and Plastic Surgery/CCT | Scottsdale | Arizona | 85260 | — |
| Center for Dermatology and Plastic Surgery | Scottsdale | Arizona | 85260 | — |
| Anaheim Clinical Trials, LLC | Anaheim | California | 92801 | — |
| Kern Research. Inc. | Bakersfield | California | 93301 | — |
| California Dermatology & Clinical Research Institute | Encinitas | California | 92024 | — |
| Imaging Healthcare Specialists | San Diego | California | 92103 | — |
| Medderm Associates Dermatology | San Diego | California | 92103 | — |
| University Clinical Trials | San Diego | California | 92123 | — |
| Renstar Medical Research | Ocala | Florida | 34470 | — |
| MidState Skin Institute | Ocala | Florida | 34471 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Advanced Diagnostic Group | Orange Park | Florida | 32073 | — |
| Park Avenue Dermatology | Orange Park | Florida | 32073 | — |
| Leavitt Medical Associates of Florida d/b/a Ameriderm Research | Ormond Beach | Florida | 32174 | — |
| ForCare Clinical Research | Tampa | Florida | 33613 | — |
| Hamilton Research, LLC | Alpharetta | Georgia | 30022 | — |
| Epiphany Dermatology of Kansas, LLC | Overland Park | Kansas | 66215 | — |
| Qualmedica Research, LLC | Owensboro | Kentucky | 42301 | — |
| Owensboro Dermatology Associates | Owensboro | Kentucky | 42303 | — |
| DelRicht Research | Baton Rouge | Louisiana | 70809 | — |
| DelRicht Research | Baton Rouge | Louisiana | 70816 | — |
| Vital Prospects Clinical Research Institute, PC | Tulsa | Oklahoma | 74136 | — |
| Arlington Research Center, Inc. | Arlington | Texas | 76011 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03895372, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 27, 2021 · Synced Nov 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.